Costello Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Costello Asset Management's VRTX Position: Q2 2026 in Review
Costello Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 6.8% in Q2 2026, buying an estimated $17.7K and bringing the position to 629 shares worth $312K. The position accounts for 0.09% of the portfolio, ranked #96.
Costello Asset Management first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $322K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Costello Asset Management held 629 shares of Vertex Pharmaceuticals worth $312K as of Q2 2026.
- Costello Asset Management bought 40 Vertex Pharmaceuticals shares in Q2 2026, an estimated $17.7K.
- Vertex Pharmaceuticals made up 0.09% of Costello Asset Management's portfolio in Q2 2026, its #96 holding.
- Costello Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Costello Asset Management's Vertex Pharmaceuticals position peaked at $322K in Q1 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.